Christoph Brackmann has served as Novocure’s Chief Financial Officer since January 2025. He oversees the company’s global financial operations, including financial reporting, financial planning and analysis, treasury, tax, and investor relations. Mr. Brackmann joined Novocure in October 2024 as a Senior Financial Advisor.

Before joining Novocure, Mr. Brackmann was Senior Vice President of Finance at Moderna since 2019. While at Moderna he established and built the finance team and oversaw the rapid expansion of the organization during the COVID-19 pandemic. Previous to this role, Mr. Brackmann served as the Vice President of Investor Relations and Head of International Finance at Shire plc (acquired by Takeda), and held various financial roles at Eli Lilly and Company, and Novartis.

Mr. Brackmann earned his Master of Business Administration from the SDA Bocconi School of Management, Milan and holds a bachelor’s degree in Business and Economics from the University of Mannheim.